Mandel et al. reported a low detection rate of lymph node metastases in intermediate-risk patients with GSs of ≤6, cT 2b or less, and PSA 10–20 ng/mL. This evidence concerns the gene KLK3 and metastatic malignant neoplasm in the lymph nodes.